The deletion of β4 integrin resulted in a pronounced inhibition of prostate tumor growth and progression in a mouse model initiated by RB and p53 loss [603]; these inhibitory effects on tumor growth were related to a defective self-renewal of cancer stem cells and to a reduced proliferation of transit-amplifying cells in vivo [603]. Here, RB1 is linked to prostate neoplasm.